OTCMKTS:OCPNY Olympus (OCPNY) Stock Price, News & Analysis $18.00 -0.25 (-1.37%) As of 01/31/2023 Add Compare Share Share Stock Analysis Stock Analysis About Olympus Stock (OTCMKTS:OCPNY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Olympus alerts:Sign Up Key Stats Today's Range$18.00▼$18.0050-Day Range$18.00▼$18.0052-Week Range$16.80▼$74.99Volume400 shsAverage Volume860,265 shsMarket Capitalization$23.15 billionP/E Ratio21.95Dividend Yield0.44%Price TargetN/AConsensus RatingN/A Company OverviewOlympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.Read More… Receive OCPNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter. Email Address OCPNY Stock News HeadlinesOlympus Corporation (OLYMY) Q2 2025 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comTim Stroble Appointed as Olympus Insurance Company Chief Executive OfficerMay 11, 2023 | finance.yahoo.comStunning Trump Manhattan Project Now UnderwayJust as I predicted, President Trump announced his #1 move during his first 100 days... His allies are calling it Trump’s Manhattan Project.January 22, 2025 | Banyan Hill Publishing (Ad)New Olympus sports complex partnership is latest in $1B+ project's progressFebruary 26, 2023 | bizjournals.comOlympus Teams Up With Sony for Surgical Big Screen TVFebruary 23, 2023 | thestreet.comOlympus says addressing FDA concerns on endoscope productionJanuary 12, 2023 | seekingalpha.comOlympus Corporation (OCPNY) Stock Historical Prices & Data - Yahoo FinanceJanuary 9, 2023 | finance.yahoo.comOlympus Corporation (OCPNY) Q3 2022 Earnings Call TranscriptNovember 12, 2022 | seekingalpha.comSee More Headlines OCPNY Stock Analysis - Frequently Asked Questions How have OCPNY shares performed this year? Olympus' stock was trading at $18.00 on January 1st, 2025. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00. View the best growth stocks for 2025 here. How were Olympus' earnings last quarter? Olympus Co. (OTCMKTS:OCPNY) posted its quarterly earnings data on Thursday, August, 5th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.03. The business earned $1.75 billion during the quarter, compared to the consensus estimate of $1.49 billion. Olympus had a trailing twelve-month return on equity of 24.30% and a net margin of 13.80%. Does Olympus have any subsidiaries? Olympus subsidiaries include FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and more. How do I buy shares of Olympus? Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/05/2021Today1/21/2025Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Structural clay products Sub-IndustryN/A Current SymbolOTCMKTS:OCPNY CUSIPN/A CIKN/A Webwww.olympus-global.com Phone(133) 340-2111Fax813-3340-2062Employees31,557Year Founded1919Profitability EPS (Most Recent Fiscal Year)$0.82 Trailing P/E Ratio21.95 Forward P/E Ratio10.91 P/E Growth1.07Net Income$1.03 billion Net Margins13.80% Pretax MarginN/A Return on Equity24.30% Return on Assets9.30% Debt Debt-to-Equity Ratio0.59 Current Ratio1.99 Quick Ratio1.48 Sales & Book Value Annual Sales$7.74 billion Price / Sales2.99 Cash Flow$1.22 per share Price / Cash Flow14.76 Book Value$3.50 per share Price / Book5.14Miscellaneous Outstanding Shares1,285,890,000Free FloatN/AMarket Cap$23.15 billion OptionableNot Optionable Beta0.70 Social Links 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (OTCMKTS:OCPNY) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olympus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olympus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.